Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laurentis Energy Partners
Toronto, Ontario, Canadalaurentisenergy.com ↗
- Ownership
- Private
- Employees
- ~384
- Development stage
- Other
01
Overview
Laurentis Energy Partners, a subsidiary of Ontario Power Generation, is commercially producing medical isotopes including lutetium-177 and yttrium-90 for cancer therapy, with regulatory clearance to expand production and a proprietary Target Delivery System; they are one of a few suppliers meeting global shortages, and their uptake is expanding rapidly in radiopharmaceuticals.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- RadiopharmaceuticalRadiopharmaceutical (yttrium-90)Radiopharmaceutical (lutetium-177)Radiopharmaceutical (molybdenum-99)Radiopharmaceutical (cobalt-60)Radiopharmaceutical (helium-3)
- Industry
- Chemicals & Materials
02
Partnerships
BWXT Medical Ltd.Colibri Isotopes Corporation
Beyond the preview
Go deeper on Laurentis Energy Partners.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laurentis Energy Partners.